OrbiMed Capital GP VII LLC, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), sold 683,942 shares at $21.31 ($14.6M) on 2022-06-24, disclosed to the SEC on 2022-06-28.
Open-market sale of $14.6M ARQT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.31 | 35,944 | $766K | 5.3% |
| 2 | $21.31 | 35,944 | $766K | 5.3% |
| 3 | $21.31 | 306,027 | $6.5M | 44.7% |
| 4 | $21.31 | 306,027 | $6.5M | 44.7% |
| Total | $21.31 avg | 683,942 | $14.6M | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |